July 17, 2024
Providers | Tea Leaves
  • The Supreme Court’s decision that overturned the longstanding Chevron deference, is expected to trigger a wave of lawsuits across the health care sector. The ruling diminishes federal agencies’ authority to interpret laws and strengthens the judiciary’s role in clarifying congressional intent, introducing significant regulatory uncertainty. Health care areas likely to face legal challenges include Medicare Advantage audits and risk adjustment methods, Dual Eligible Special Needs Plans (D-SNP) requirements, critical access hospital eligibility, nursing home staffing mandates, and digital health reimbursement policies. The decision could lead to substantial changes in regulatory oversight and judicial scrutiny, potentially impacting health care providers, insurers, and patients alike. (Article here)